GlassScriptPhysician profile
Paul Appleby
NPI 1366806242
$775.16
in general payments reported to CMS, 2019-2025
17 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $56.43 · 2022: $78.43 · 2023: $84.24 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $250.31 | 2025 | |
| Ethicon US, LLC | $128.19 | 2025 | Echelon Endopath |
| Acell, INC. | $70.66 | 2019-2020 | |
| Organogenesis INC. | $33.01 | 2022 | |
| Smith+Nephew, INC. | $30.90 | 2022-2023 | Pico, Renasys Go V2 Home |
| Kci USA, INC. | $30.81 | 2019 | |
| Atricure, INC. | $29.59 | 2019 | |
| Conmed Corporation | $29.17 | 2023 | Airseal |
| Davol INC. | $25.69 | 2025 | Ventralight St |
| Intra-Sana Laboratories | $25.37 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Medtronic, INC. | $24.02 | 2023 | Symbotex |
| Olympus America INC. | $21.43 | 2025 | Olympus |
| Convatec INC. | $18.40 | 2020 | |
| Tela Bio, INC. | $16.66 | 2022 | |
| Next Science LLC | $16.09 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.82 | 2023 | Spyglass Discover |
| Cook Medical LLC | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Appleby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.